Mast Cells Down-Regulate CD4+CD25+ T Regulatory Cell Suppressor Function via Histamine H1 Receptor Interaction

被引:61
作者
Forward, Nicholas A. [1 ]
Furlong, Suzanne J. [1 ]
Yang, Yongjun [2 ]
Lin, Tong-Jun [1 ,2 ]
Hoskin, David W. [1 ,3 ,4 ]
机构
[1] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada
[2] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 1X5, Canada
[3] Dalhousie Univ, Dept Pathol, Halifax, NS B3H 1X5, Canada
[4] Dalhousie Univ, Dept Surg, Halifax, NS B3H 1X5, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
TRANSCRIPTION FACTOR FOXP3; IN-VITRO; MEDIATED SUPPRESSION; CUTTING EDGE; TARGET GENES; GRANZYME-B; TOLL-LIKE; ACTIVATION; IL-2; EXPRESSION;
D O I
10.4049/jimmunol.0802509
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mast cells promote both innate and acquired immune responses, but little is known about the effect of mast cells on T regulatory (T-reg) cell function. In this study, we show for the first time that the capacity of murine CD4(+)CD25(+) T-reg cells to suppress in vitro proliferation by CD4(+)CD25(+) T responder (T-resp) cells in response to anti-CD3/anti-CD28 mAb-coated beads was reduced in the presence of syngeneic bone marrow-derived mast cells (BMMC) activated by Fc epsilon R cross-linking. Activated BMMC culture supernatants or exogenous histamine also inhibited T-reg cell suppressor function while the histamine H1 receptor-specific antagonist loratadine, but not the H2 receptor-specific antagonist famotidine, restored T-reg cell suppressor function in the presence of activated BMMC or activated BMMC culture supernatants. Moreover, treatment of T-reg cells with loratadine, but not famotidine, rescued T-reg cell suppressor function in the presence of exogenous histamine. In addition, the H1 receptor-specific agonist 2-pyridylethylamine dihydrochloride inhibited T-reg cell suppressor function to an extent that was comparable to histamine, whereas the H2 receptor-specific agonist amthamine dihydrobromide was without effect. Both T-reg cells and T-reg cells expressed H1 receptors. Exposure to histamine caused T-reg cells to express lower levels of CD25 and the T-reg cell-specific transcription factor Foxp3. Taken together, these data indicate that BMMC-elaborated histamine inhibited T-reg cell suppressor function by signaling through the H1 receptor. We suggest that histamine released as a result of mast cell activation by microbial products might cause a transient decrease in T-reg cell suppressor function, thereby enhancing the development of protective immunity. The Journal of Immunology, 2009, 183: 3014-3022.
引用
收藏
页码:3014 / 3022
页数:9
相关论文
共 46 条
  • [11] HISTAMINE-H2-RECEPTOR AGONISTS - SYNTHESIS, INVITRO PHARMACOLOGY, AND QUALITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS OF SUBSTITUTED 4-(2-AMINOETHYL)THIAZOLES AND 5-(2-AMINOETHYL)THIAZOLES
    ERIKS, JC
    VANDERGOOT, H
    STERK, GJ
    TIMMERMAN, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (17) : 3239 - 3246
  • [12] Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells
    Fehérvári, Z
    Sakaguchi, S
    [J]. INTERNATIONAL IMMUNOLOGY, 2004, 16 (12) : 1769 - 1780
  • [13] Regulatory T cell lineage specification by the forkhead transcription factor FoxP3
    Fontenot, JD
    Rasmussen, JP
    Williams, LM
    Dooley, JL
    Farr, AG
    Rudensky, AY
    [J]. IMMUNITY, 2005, 22 (03) : 329 - 341
  • [14] Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003)
    Fontenot, Jason D.
    Gavin, Marc A.
    Rudensky, Alexander Y.
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (03) : 986 - 992
  • [15] Cutting edge:: Contact-mediated suppression by CD4+-CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism
    Gondek, DC
    Lu, LF
    Quezada, SA
    Sakaguchi, S
    Noelle, RJ
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (04) : 1783 - 1786
  • [16] Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis
    Heuer, JG
    Zhang, TH
    Zhao, JY
    Ding, CJ
    Cramer, M
    Justen, KL
    Vonderfecht, SL
    Na, SQ
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (11) : 7141 - 7146
  • [17] Control of regulatory T cell development by the transcription factor Foxp3
    Hori, S
    Nomura, T
    Sakaguchi, S
    [J]. SCIENCE, 2003, 299 (5609) : 1057 - 1061
  • [18] FAMOTIDINE, A NEW, POTENT, LONG-ACTING HISTAMINE H2-RECEPTOR ANTAGONIST - COMPARISON WITH CIMETIDINE AND RANITIDINE IN THE TREATMENT OF ZOLLINGER-ELLISON SYNDROME
    HOWARD, JM
    CHREMOS, AN
    COLLEN, MJ
    MCARTHUR, KE
    CHERNER, JA
    MATON, PN
    CIARLEGLIO, CA
    CORNELIUS, MJ
    GARDNER, JD
    JENSEN, RT
    [J]. GASTROENTEROLOGY, 1985, 88 (04) : 1026 - 1033
  • [19] Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors
    Jutel, M
    Watanabe, T
    Klunker, S
    Akdis, M
    Thomet, OAR
    Malolepszy, J
    Zak-Nejmark, T
    Koga, R
    Kobayashi, T
    Blaser, K
    Akdis, CA
    [J]. NATURE, 2001, 413 (6854) : 420 - 425
  • [20] CD4 T cell-mast cell interactions alter IgE receptor expression and signaling
    Kashyap, Mohit
    Thornton, Angela M.
    Norton, Sarah Kennedy
    Barnstein, Brian
    Macey, Matthew
    Brenzovich, Jennifer
    Shevach, Ethan
    Leonard, Warren J.
    Ryan, John J.
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (04) : 2039 - 2043